Nanocarriers for Skin Applications: Where Do We Stand?

Angew Chem Int Ed Engl. 2022 Jan 17;61(3):e202107960. doi: 10.1002/anie.202107960. Epub 2021 Oct 1.

Abstract

Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic-derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is generally challenging due to the low skin permeability of therapeutics. Although various methods have been developed to improve skin penetration and permeation of therapeutics, they are usually aggressive and could lead to irreversible damage to the stratum corneum. Nanosized carrier systems represent an alternative approach for current technologies, with minimal damage to the natural barrier function of skin. In this Review, the use of nanoparticles to deliver drug molecules, genetic material, and vaccines into the skin is discussed. In addition, nanotoxicology studies and the recent clinical development of nanoparticles are highlighted to shed light on their potential to undergo market translation.

Keywords: drug delivery; gene expression; nanoparticles; skin penetration; transdermal vaccination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Carriers / chemistry
  • Humans
  • Nanoparticles / chemistry*
  • Skin / chemistry*

Substances

  • Drug Carriers